Cargando…
Integrative Genetic Characterization and Phenotype Correlations in Pheochromocytoma and Paraganglioma Tumours
BACKGROUND: About 60% of Pheochromocytoma (PCC) and Paraganglioma (PGL) patients have either germline or somatic mutations in one of the 12 proposed disease causing genes; SDHA, SDHB, SDHC, SDHD, SDHAF2, VHL, EPAS1, RET, NF1, TMEM127, MAX and H-RAS. Selective screening for germline mutations is rout...
Autores principales: | Crona, Joakim, Nordling, Margareta, Maharjan, Rajani, Granberg, Dan, Stålberg, Peter, Hellman, Per, Björklund, Peyman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899286/ https://www.ncbi.nlm.nih.gov/pubmed/24466223 http://dx.doi.org/10.1371/journal.pone.0086756 |
Ejemplares similares
-
Next-generation sequencing in the clinical genetic screening of patients with pheochromocytoma and paraganglioma
por: Crona, Joakim, et al.
Publicado: (2013) -
Global DNA Methylation Analysis Identifies Two Discrete clusters of Pheochromocytoma with Distinct Genomic and Genetic Alterations
por: Backman, Samuel, et al.
Publicado: (2017) -
RNA-Sequencing Analysis of Adrenocortical Carcinoma, Pheochromocytoma and Paraganglioma from a Pan-Cancer Perspective
por: Crona, Joakim, et al.
Publicado: (2018) -
Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with (177)Lu-DOTATATE
por: Vyakaranam, Achyut Ram, et al.
Publicado: (2019) -
(11)C-hydroxy-ephedrine-PET/CT in the Diagnosis of Pheochromocytoma and Paraganglioma
por: Vyakaranam, Achyut Ram, et al.
Publicado: (2019)